May 12, 2022
3 min watch
Save
VIDEO: Ocuphire shares latest in oral tablet for treatment of retinal disease
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
FORT LAUDERDALE, Fla. — In this Healio Video Perspective from the Retina World Congress, Mina Sooch, founder and CEO of Ocuphire Pharma, updates the latest research in the development of APX3330 oral tablet to treat retinal disease.